314 related articles for article (PubMed ID: 31147311)
21. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study.
Knobbe TJ; Kremer D; Douwes RM; Eisenga MF; Gomes-Neto AW; Annema C; Swarte JC; Klont F; Navis G; Berger SP; Bakker SJL;
Am J Kidney Dis; 2023 Aug; 82(2):189-201.e1. PubMed ID: 36801431
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal tuberculosis is not associated with proton pump inhibitors: a retrospective cohort study.
Hong KS; Kang SJ; Choi JK; Kim JH; Seo H; Lee S; Jung JW; Kang HR; Cho SH; Kim JS
World J Gastroenterol; 2013 Jan; 19(2):258-64. PubMed ID: 23345949
[TBL] [Abstract][Full Text] [Related]
23. Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study.
Kurlander JE; Laine L; Kim HM; Roberts CB; Saffar D; Myers A; Holleman R; Gao Y; Shank M; Nelson R; Forman J; Helfrich CD; Krein SL; Saini SD; Yang YX
BMJ; 2024 Apr; 385():e076484. PubMed ID: 38604668
[TBL] [Abstract][Full Text] [Related]
24. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
[TBL] [Abstract][Full Text] [Related]
25. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
Ho PM; Maddox TM; Wang L; Fihn SD; Jesse RL; Peterson ED; Rumsfeld JS
JAMA; 2009 Mar; 301(9):937-44. PubMed ID: 19258584
[TBL] [Abstract][Full Text] [Related]
26. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
[TBL] [Abstract][Full Text] [Related]
27. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
[TBL] [Abstract][Full Text] [Related]
28. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
[TBL] [Abstract][Full Text] [Related]
29. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
[TBL] [Abstract][Full Text] [Related]
30. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
[TBL] [Abstract][Full Text] [Related]
31. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
[TBL] [Abstract][Full Text] [Related]
32. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
[TBL] [Abstract][Full Text] [Related]
33. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
34. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
[TBL] [Abstract][Full Text] [Related]
35. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
[TBL] [Abstract][Full Text] [Related]
36. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M; Tafreshi J; Pai RG
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
[TBL] [Abstract][Full Text] [Related]
37. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP;
J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778
[TBL] [Abstract][Full Text] [Related]
38. Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population.
Christensen CH; Rostron B; Cosgrove C; Altekruse SF; Hartman AM; Gibson JT; Apelberg B; Inoue-Choi M; Freedman ND
JAMA Intern Med; 2018 Apr; 178(4):469-476. PubMed ID: 29459935
[TBL] [Abstract][Full Text] [Related]
39. Association of Proton Pump Inhibitor Use With All-Cause and Cause-Specific Mortality.
Lo CH; Ni P; Yan Y; Ma W; Joshi AD; Nguyen LH; Mehta RS; Lochhead P; Song M; Curhan GC; Cao Y; Chan AT
Gastroenterology; 2022 Oct; 163(4):852-861.e2. PubMed ID: 35788344
[TBL] [Abstract][Full Text] [Related]
40. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study.
Coblijn UK; Lagarde SM; de Castro SM; Kuiken SD; van Tets WF; van Wagensveld BA
Surg Obes Relat Dis; 2016 Feb; 12(2):246-52. PubMed ID: 26381875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
